Medical marijuana is moving from Schedule I status, reserved for the most dangerous drugs like heroin and LSD, to Schedule III, like testosterone and steroids, which are less strictly regulated.

Trump administration to reclassify marijuana as Schedule III, easing research barriers but not legalizing the drug or ...

The Trump administration is seeking to reclassify cannabis as a less dangerous substance Thursday, moving it from Schedule I ...

Cannabis stocks and funds that hold them surged after the Trump administration moved it from the government most restrictive ...

Marijuana stocks sold off Thursday, after acting U.S. Attorney General Todd Blanche signed an order rescheduling FDA-approved ...

New DOJ Order Removes 280E Tax Burden for State-Licensed Medical Cannabis Operators, Potentially Expanding Safe Harbor's Client Base and Managed Services OpportunityDENVER, April 24, 2026 (GLOBE ...

Department of Justice is immediately loosening restrictions on some marijuana products and accelerating the process of ...

As was roughly anticipated, the Trump administration has moved to partially reclassify marijuana, announcing on Thursday that ...

The federal government is reclassifying medical cannabis from a Schedule I drug to a Schedule III drug, but Nebraska ...

MSOS's metric understates risk by excluding large tax liabilities, especially for CURLF and TCNNF. Learn more about the MSOS ...

A new rule loosening restrictions on medical marijuana will normalize it as a treatment option for senior living residents seeking relief from pain, sleep disorders and dementia-related agitation, ...

The Connecticut legislation would eliminate state caps on THC concentration in cannabis flower and raise THC limits in ...